Location: Barcelona, Spain
Date: September 16 to September 20
European Association for the Study of Diabetes.
Highlights of the 2019 EASD Congress
DAPA HF : The Dapagliflozin And Prevention Of Adverse‑ outcomes In Heart Failure Trial
Early intervention with oral semaglutide and long term safety
VERIFY and CONCLUDE study
Clinical properties and differences between GLP-1 agonists
Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes
Diabetic retinopathy: Is the eye a mirror of the brain?